All In Biotech

Free tool

FAERS Monitor: Metadate Cd

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021259 or its brand name (Metadate Cd, Methylphenidate Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

7,354

Serious

4,534

62% of reports

Hospitalization

1,756

Death reported

445

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,098
  • headache417
  • fatigue370
  • anxiety363
  • off label use347
  • nausea346
  • toxicity to various agents334
  • product substitution issue299
  • drug abuse286
  • insomnia283
  • somnolence282
  • disturbance in attention245
  • suicidal ideation245
  • decreased appetite235
  • agitation227

Reports by year received

View as table
YearReports
200422
200518
200618
200725
200826
200930
201028
201132
201290
2013120
2014127
2015465
2016401
2017512
2018591
2019473
2020370
2021412
2022619
2023794
2024752
2025746
2026683

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,805 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product substitution issueSignal29914.913.43,861
disturbance in attentionSignal24513.011.52,708
drug abuseSignal2869.98.82,268
agitationSignal2278.97.81,577
suicidal ideationSignal2457.76.81,417
toxicity to various agentsSignal3345.75.11,289
somnolenceSignal2824.03.6639
anxietySignal3633.73.3705
insomniaSignal2833.02.7390
decreased appetiteSignal2352.92.6293
drug ineffectiveSignal1,0982.42.3939
headache4171.91.7183
fatigue3701.41.236
nausea3461.31.118
off label use3471.11.06

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.